Filing Details

Accession Number:
0001209191-10-039919
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-28 13:00:00
Reporting Period:
2010-07-26
Filing Date:
2010-07-28
Accepted Time:
2010-07-28 16:41:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353230 Omnicare Inc NYSE: OCR Retail-Drug Stores And Proprietary Stores (5912) 311001351
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224637 F Joel Gemunder 100 E. Rivercenter Blvd., Suite 1600
Covington KY 41011
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-07-26 1,714 $16.53 1,541,757 No 4 M Direct
Common Stock Disposition 2010-07-26 1,343 $25.70 1,540,414 No 4 F Direct
Common Stock Disposition 2010-07-26 371 $26.50 1,540,043 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2010-07-26 1,714 $0.00 1,714 $16.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-11-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 155,007 Indirect By Family Trust
Common Stock 155,008 Indirect By Family Trust
Common Stock 391,295 Indirect By GRAT
Common Stock 307,828 Indirect Shares held in Savings & Investment Plan, ESOP and Excess Benefit Plan as of 03/31/2010.
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by reporting person on June 10, 2010.
  2. The sales price represents the weighted average sales price ranging in price from $26.50 to $26.51. The number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
  3. Includes 30,410 shares acquired in exempt transactions under the Omnicare StockPlus Program (broad-based stock purchase/option plan).
  4. Options vest in full 4 years after date of grant.